Iron Supplements Market (By Type: Oral Iron Therapy, Parental Iron Therapy, Red Blood Cell Therapy, Other Therapy Types, By End- user: Pregnancy Consumer, Ordinary Consumer, Anemia Consumer, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global iron supplements market size was valued at USD 2.59 billion in 2023 and is anticipated to reach around USD 3.76 billion by 2033, growing at a CAGR of 3.82% from 2024 to 2033. The iron supplements market is driven by the growing incidence of iron deficiency anemia (IDA), especially in specific populations.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The industry sector devoted to creating, supplying, and marketing dietary supplements containing iron is known as the iron supplements market. The main reason people take iron supplements is to treat iron deficiency, which, if unchecked, can result in anemia. Many biological processes, such as the transportation of oxygen, the metabolism of energy, and the production of DNA, depend on iron. Iron deficiency can cause several health problems, including weakness, exhaustion, and reduced cognitive function. Certain groups of people are more likely to suffer from iron deficiency than others, including expectant mothers, young children, teenagers, and people with certain medical conditions, including gastrointestinal or chronic illnesses. Therefore, the market fills a vital demand by offering practical and approachable ways to boost iron levels and enhance general health and well-being.
Report Coverage | Details |
Growth Rate from 2024 to 2033 | CAGR of 3.82% |
Global Market Size in 2023 | USD 2.59 Billion |
Global Market Size in 2024 | USD 2.69 Billion |
Global Market Size by 2033 | USD 3.76 Billion |
Largest Market | North America |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | By Type and By End-use |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Drivers
Individuals engaged in strenuous physical activity
Performing high-intensity exercises, endurance training, or participating in competitive sports puts significant stress on the body's resources, especially iron. Hemoglobin, a protein found in red blood cells that transports oxygen from the lungs to the body's tissues, is produced only with iron. When engaging in vigorous physical activity, the body requires more oxygen, which raises the need for hemoglobin synthesis. This calls for enough iron to be available. Due to their extended, repetitive workout regimens, endurance athletes like cyclists, triathletes, and marathon runners are especially vulnerable to iron deficiency. If left untreated, iron deficiency anemia is frequently caused by increased iron loss through sweat, gastrointestinal bleeding, low nutritional intake, and inadequate absorption.
Increased consumption of processed foods and diets lacking in iron-rich foods
Processed foods are popular among many individuals, especially those who lead hectic lifestyles because they are easily accessible and convenient. Moreover, convenience frequently comes at the expense of nutritional value. People who eat more processed food may unintentionally consume less iron-rich foods like beans, lean meats, and leafy greens as their diet becomes more processed.
Restraint
Lack of awareness about iron deficiency
Regular iron deficiency screening is not shared worldwide, particularly in populations where the prevalence of iron insufficiency is not considered high. This implies that even those at risk cannot be recognized in time to receive the right help. A multimodal strategy is typically necessary to treat iron shortage, involving dietary modifications, supplements, and, in extreme situations, intravenous iron therapy. Treatment suggestions may not be followed because of resistance or ignorance of the significance of these interventions and the possible repercussions of untreated iron deficiency.
Opportunities
Availability of iron supplements through various distribution channels
A wider population can now obtain iron supplements because they are distributed in various ways. No matter where they live or how mobile they are, people can readily get iron supplements thanks to traditional channels, including pharmacies, supermarkets, health stores, and internet businesses. The iron supplements market can reach a wider demographic by leveraging various distribution channels, such as underserved groups.
This is especially crucial in areas with restricted access to pharmacies or medical services. For example, geographical constraints can be overcome by online distribution methods, which allow people living in rural areas to obtain iron supplements without having to travel great distances.
Growing awareness about the importance of maintaining overall health and well-being
An increasing number of people are becoming aware of the incidence and effects of iron deficiency because of growing education and awareness initiatives on nutrition and health. Iron is essential for the body to produce energy, carry oxygen, and maintain the immune system. People are more inclined to look for ways to manage iron deficiency as they become more aware of its symptoms and consequences, which increases demand for iron supplements.
The oral iron therapy segment dominated the iron supplements market in 2023. Oral iron therapy is widely recommended because it is so successful in treating iron deficiency anemia. Oral iron therapy usually entails taking iron supplements in the form of pills or capsules. Since these supplements are easily obtained over the counter and meant to be taken orally, patients can conveniently give them on their own without requiring medical supervision.
These supplements are widely accessible to customers worldwide and may be found at pharmacies, drugstores, and online platforms. Patients can readily obtain these supplements without encountering substantial barriers to access, contributing to the oral iron therapy segment's dominance in the market.
The red blood cell therapy segment is observed to show a significant growth in the iron supplements market during the forecast period. Red blood cell therapy, which is high in iron and hemoglobin, is a possible treatment for severe cases of iron deficiency anemia. Red blood cells are transfused directly into the patients' bloodstreams as part of this therapy. RBC therapy can help people with severe anemia more quickly than standard oral iron supplements, especially if they have trouble absorbing iron via their digestive tract.
Clinical research and empirical data have shown that red blood cell treatment effectively treats severe iron deficient anemia. Hemoglobin levels in patients undergoing red blood cell transfusions frequently improve quickly, providing symptomatic relief and enhancing quality of life. Due to positive patient outcomes, the market for iron supplements has shown a notable increase in demand.
The parental iron therapy segment shows notable growth in the iron supplements market during the forecast period. Parenteral iron therapy is the injection of iron intramuscularly or intravenously into the bloodstream. This technique guarantees quick iron absorption into the body by avoiding the gastrointestinal tract, where absorption may be hampered by conditions such a poor diet, digestive problems, or drug interaction. As a result, iron levels are frequently replenished in patients more quickly than with oral supplements, which makes it a desirable choice for people with severe iron insufficiency or malabsorption problems.
The anemia consumer segment dominated the iron supplements market in 2023. Anemia is a common condition worldwide, generally due to a lack of hemoglobin in the blood. Anemia is more common in several demographic groups, such as old people, newborns, teenagers, and fertile women. The need for iron supplementation to treat or prevent anemia is higher in these populations. Accessibility and cost are critical factors in the anemic customer segment's market domination for iron supplements. Consumer access has been helped by initiatives to make iron supplements easily accessible in pharmacies, grocery stores, and internet marketplaces.
The pregnancy consumer segment is observed to be the fastest growing iron supplements market during the forecast period. Iron deficiency anemia (IDA) is common in expectant mothers worldwide. As access to prenatal care expands and healthcare infrastructure improves, an increasing number of IDA cases are diagnosed. As a result, medical professionals stress the importance of taking iron supplements to avoid pregnancy-related issues like low birth weight and preterm delivery. Expectant moms value their unborn child's health above all else and are prepared to spend money on dietary supplements that promote fetal development. Iron is necessary for the transfer of oxygen, essential for the growth and development of the fetus's brain. Pregnant women are motivated to look for iron supplements to secure the best possible health for their unborn child.
North America held the largest share of the iron supplements market in 2023. The region is observed to sustain the position throughout the forecast period. Iron insufficiency in North America is a prevalent health problem affecting people of all ages and socioeconomic backgrounds. Bad eating habits, blood loss from menstruation, and specific medical disorders influence this occurrence. As a result, there is a constant need for iron supplements to treat this inadequacy. The pharmaceutical and nutraceutical sectors in the area are always coming up with new and improved ways to formulate iron supplements. Products with improved bioavailability, creative administration methods, or increased nutritional value might be among these breakthroughs. These developments support consumer preferences for convenient and effective supplementation, increasing market expansion.
Asia-Pacific is the fastest growing iron supplements market during the forecast period. Due to poor dietary practices, restricted availability of nutrient-rich foods, and a high prevalence of illnesses such as gastrointestinal diseases that can impair iron absorption, iron insufficiency is a serious health concern in many parts of Asia-Pacific. As a result, there is a growing market for iron supplements as people look for ways to meet their dietary needs and avoid becoming sick. Online retail platforms are becoming increasingly popular as an alternative to conventional brick-and-mortar pharmacies and health stores for buying supplements. It is now simpler for customers to get iron supplements because of this increased accessibility.
Segments Covered in the Report
By Type
By End-user
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Iron Supplements Market
5.1. COVID-19 Landscape: Iron Supplements Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Iron Supplements Market, By Type
8.1. Iron Supplements Market Revenue and Volume, by Type, 2024-2033
8.1.1. Oral Iron Therapy
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Parental Iron Therapy
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Red Blood Cell Therapy
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Other Therapy Types
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Iron Supplements Market, By End-user
9.1. Iron Supplements Market Revenue and Volume, by End-user, 2024-2033
9.1.1. Pregnancy Consumer
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Ordinary Consumer
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Anemia Consumer
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Others
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Iron Supplements Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.1.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.1.3.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.1.4.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.2.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.2.3.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.2.4.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.2.5.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.2.6.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.3.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.3.3.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.3.4.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.3.5.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.3.6.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.4.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.4.3.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.4.4.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.4.5.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.4.6.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.5.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.5.3.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
10.5.4.2. Market Revenue and Volume Forecast, by End-user (2021-2033)
Chapter 11. Company Profiles
11.1. Amieson
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Pronova Corporation
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Olly Nutrition
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Walgreens
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Mineral BioSciences
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Nature Made
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Ferro Sequels
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. NovaFerrum
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Twinlab
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. ACGrace
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client